Course and predictors of cognitive function in patients with prostate cancer receiving androgen-deprivation therapy: A controlled comparison

Journal of Clinical Oncology

Volumn 33, Issue 18, 2015, Pages 2021-2027

  Gonzalez, Brian D ^a   Jim, Heather S L ^a   Booth Jones, Margaret ^a   Small, Brent J ^b   Sutton, Steven K ^a   Lin, Hui Yi ^a   Park, Jong Y ^a   Spiess, Philippe E ^a   Fishman, Mayer N ^a   Jacobsen, Paul B ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN;

AGED; ALLELE; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER HORMONE THERAPY; CANCER SURGERY; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; COGNITIVE RESERVE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; EDUCATIONAL STATUS; FATIGUE; GENE; GENETIC ANALYSIS; GENOTYPE; GLEASON SCORE; GNB3 GENE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; COMPLICATION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PROSTATIC NEOPLASMS;

AGED; ANDROGEN ANTAGONISTS; COGNITION; COGNITION DISORDERS; DEPRESSION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 84973304615     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.60.1963     Document Type: Article

References (54)

1. Ahles TA, Root JC, Ryan EL: Cancer-and cancer treatment-associated cognitive change: An update on the state of the science. J Clin Oncol 30:3675-3686, 2012
2. Siegel R, Ma J, Zou Z, et al: Cancer statistics, 2014. CA Cancer J Clin 64:9-29, 2014
3. Gilbert SM, Kuo YF, Shahinian VB: Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States. Urol Oncol 6:647-653, 2011
4. Lee M, Jim HS, Fishman M, et al: Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: A controlled comparison. Psychooncology [epub ahead of print on June 13, 2014]
5. Storey DJ, McLaren DB, Atkinson MA, et al: Clinically relevant fatigue in men with hormonesensitive prostate cancer on long-term androgen deprivation therapy. Ann Oncol 23:1542-1549, 2012
6. Holland J, Bandelow S, Hogervorst E: Testosterone levels and cognition in elderly men: A review. Maturitas 69:322-337, 2011
7. Jim HS, Small BJ, Patterson S, et al: Cognitive impairment in men treated with luteinizing hormone-releasing hormone agonists for prostate cancer: A controlled comparison. Support Care Cancer 18:21-27, 2010
8. Joly F, Alibhai S, Galica J, et al: Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol 176: 2443-2447, 2006
9. Alibhai SMH, Breunis H, Timilshina N, et al: Impact of androgen-deprivation therapy on cognitive function in men with nonmetastatic prostate cancer. J Clin Oncol 28:5030-5037, 2010
10. McGinty HL, Phillips KM, Jim HS, et al: Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: A systematic review and meta-analysis. Support Care Cancer 22: 2271-2280, 2014
11. Ahles TA, Saykin AJ, Noll WW, et al: The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psychooncology 12:612-619, 2003
12. Small BJ, Rawson KS, Walsh E, et al: Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors. Cancer 117:1369-1376, 2011
13. Ahles TA, Saykin AJ, McDonald BC, et al: Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: Impact of age and cognitive reserve. J Clin Oncol 28:4434-4440, 2010
14. Snyder HR: Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-analysis and review. Psychol Bull 139:81-132, 2013
15. McDermott LM, Ebmeier KP: A meta-analysis of depression severity and cognitive function. J Affect Disord 119:1-8, 2009
16. Maki PM, Drogos LL, Rubin LH, et al: Objective hot flashes are negatively related to verbal memory performance in midlife women. Menopause 15:848-856, 2008
17. Minton O, Stone PC: A comparison of cognitive function, sleep and activity levels in disease-free breast cancer patients with or without cancer-related fatigue syndrome. BMJ Support Palliat Care 2:231-238, 2012
18. Wefel JS, Vardy J, Ahles T, et al: International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703-708, 2011
19. Lezak M: Neuropsychological Assessment (ed 3). New York, NY, Oxford University Press, 1995
20. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
21. Benedict RH, Schretlen D, Groninger L, et al: Hopkins Verbal Learning Test-Revised: Normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol 12:43-55, 1998
22. Wechsler D: Wechsler Memory Scale (WMS-III). San Antonio, TX, Psychological Corporation, 1997
23. Benedict RH: Brief Visuospatial Memory Test-Revised: Professional Manual. Odessa, FL, Psychological Assessment Resources, 1997
24. D'Elia L: Color Trails Test: Professional Manual. Odessa, FL, Psychological Assessment Resources, 1996
25. Smith A: Symbol Digit Modalities Test: Manual. Torrance, CA, Western Psychological Corporation, 2002
26. Spreen O, Straus E: A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (ed 2). New York, NY, Oxford University Press, 1998
27. Owsley C, Sloane M, McGwin G Jr, et al: Timed instrumental activities of daily living tasks: Relationship to cognitive function and everyday performance assessments in older adults. Gerontology 48:254-265, 2002
28. Nelson HE, Willison J: National Adult Reading Test (NART). Windsor, United Kingdom, Nfer- Nelson, 1991
29. Radloff LS: The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1:385-401, 1977
30. Hann DM, Jacobsen PB, Azzarello LM, et al: Measurement of fatigue in cancer patients: Development and validation of the Fatigue Symptom Inventory. Qual Life Res 7:301-310, 1998
31. Carpenter JS: The Hot Flash Related Daily Interference Scale: A tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 22:979-989, 2001
32. Jim HS, Park JY, Permuth-Wey J, et al: Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: Preliminary findings. Brain Behav Immun 26:1030-1036, 2012
33. Bower JE, Ganz PA, Tao ML, et al: Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res 15:5534-5540, 2009
34. Korfage I, Essink-Bot M, Janssens A, et al: Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up. Br J Cancer 94:1093-1098, 2006
35. Beer TM, Benavides M, Emmons SL, et al: Acupuncture for hot flashes in patients with prostate cancer. Urology 76:1182-1188, 2010
36. Ulloa EW, Salup R, Patterson SG, et al: Relationship between hot flashes and distress in men receiving androgen deprivation therapy for prostate cancer. Psychooncology 18:598-605, 2009
37. International HapMap Consortium: The International HapMap Project. Nature 426:789-796, 2003
38. Newell A, Rosenbloom PS: Mechanisms of skill acquisition and the law of practice, in Anderson JR (ed): Cognitive Skills and Their Acquisition. Hillsdale, NJ, Lawrence Earlbaum Associates, 1981, pp 1-55
39. Shilling V, Jenkins V, Trapala IS: The (mis)classification of chemo-fog-methodological inconsistencies in the investigation of cognitive impairment after chemotherapy. Breast Cancer Res Treat 95:125-129, 2006
40. Vardy J, Rourke S, Tannock IF: Evaluation of cognitive function associated with chemotherapy: A review of published studies and recommendations for future research. J Clin Oncol 25:2455-2463, 2007
41. Diggle P, Heagerty P, Liang KY, et al: Analysis of Longitudinal Data (ed 2). New York, NY, Oxford University Press, 2002
42. Storey JD: A direct approach to false discovery rates. J R Stat Soc Series B Stat Methodol 64:479-498, 2002
43. Jansen CE, Cooper BA, Dodd MJ, et al: A prospective longitudinal study of chemotherapyinduced cognitive changes in breast cancer patients. Support Care Cancer 19:1647-1656, 2011
44. Wefel JS, Saleeba AK, Buzdar AU, et al: Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:3348-3356, 2010
45. Wefel JS, Vidrine DJ, Veramonti TL, et al: Cognitive impairment in men with testicular cancer prior to adjuvant therapy. Cancer 117:190-196, 2011
46. Correa DD, Satagopan J, Baser RE, et al: APOE polymorphisms and cognitive functions in patients with brain tumors. Neurology 83:320-327, 2014
47. Koleck TA, Bender CM, Sereika SM, et al: Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer. Oncol Nurs Forum 41:E313-E325, 2014
48. Ruano D, Abecasis GR, Glaser B, et al: Functional gene group analysis reveals a role of synaptic heterotrimeric G proteins in cognitive ability. Am J Hum Genet 86:113-125, 2010
49. Bullido MJ, Ramos MC, Ruiz-Gómez A, et al: Polymorphism in genes involved in adrenergic signaling associated with Alzheimer's. Neurobiol Aging 25:853-859, 2004
50. Johnson AD, Handsaker RE, Pulit SL, et al: SNAP: A Web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24:2938-2939, 2008
51. Casiglia E, Giordano N, Tikhonoff V, et al: Cognitive functions across the GNB3 C825T polymorphism in an elderly Italian population. Neurol Res Int 2013:597034, 2013
52. Chen PS, Yeh TL, Lee IH, et al: Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers: A SPECT study. Neuroimage 56:1526-1530, 2011
53. Evans DS, Parimi N, Nievergelt CM, et al: Common genetic variants in ARNTL and NPAS2 and at chromosome 12p13 are associated with objectively measured sleep traits in the elderly. Sleep 36:431-446, 2013
54. López-León S, Janssens A, González-Zuloeta Ladd A, et al: Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry 13:772-785, 2007